A detailed history of Ubs Group Ag transactions in Biomerica Inc stock. As of the latest transaction made, Ubs Group Ag holds 91,692 shares of BMRA stock, worth $27,507. This represents 0.0% of its overall portfolio holdings.

Number of Shares
91,692
Holding current value
$27,507
% of portfolio
0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.28 - $0.49 $25,673 - $44,929
91,692 New
91,692 $30,000
Q1 2024

May 13, 2024

BUY
$0.82 - $1.29 $22,936 - $36,082
27,971 Added 550.61%
33,051 $27,000
Q4 2023

Feb 09, 2024

BUY
$0.71 - $1.65 $1,965 - $4,568
2,769 Added 119.82%
5,080 $6,000
Q3 2023

Nov 09, 2023

BUY
$0.82 - $1.65 $972 - $1,956
1,186 Added 105.42%
2,311 $1,000
Q2 2023

Aug 11, 2023

SELL
$1.12 - $1.87 $369 - $617
-330 Reduced 22.68%
1,125 $1,000
Q1 2023

May 12, 2023

SELL
$1.86 - $3.56 $887 - $1,698
-477 Reduced 24.69%
1,455 $2,000
Q4 2022

Feb 08, 2023

BUY
$2.98 - $4.17 $1,710 - $2,393
574 Added 42.27%
1,932 $6,000
Q3 2022

Nov 10, 2022

BUY
$2.61 - $3.98 $3,544 - $5,404
1,358 New
1,358 $5,000
Q2 2022

Aug 10, 2022

SELL
$2.7 - $4.69 $6,520 - $11,326
-2,415 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$3.59 - $4.64 $3,686 - $4,765
1,027 Added 73.99%
2,415 $11,000
Q4 2021

Feb 14, 2022

BUY
$3.89 - $6.71 $5,399 - $9,313
1,388 New
1,388 $5,000
Q3 2021

Nov 15, 2021

SELL
$3.54 - $5.13 $3,270 - $4,740
-924 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$3.41 - $5.9 $3,150 - $5,451
924 New
924 $4,000
Q4 2020

Feb 11, 2021

SELL
$4.71 - $7.85 $9,420 - $15,700
-2,000 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$5.86 - $12.04 $2,930 - $6,020
-500 Reduced 20.0%
2,000 $14,000
Q2 2020

Jul 31, 2020

BUY
$5.17 - $8.95 $7,020 - $12,154
1,358 Added 118.91%
2,500 $18,000
Q1 2020

May 01, 2020

BUY
$2.37 - $16.0 $2,706 - $18,272
1,142 New
1,142 $8,000
Q2 2019

Aug 14, 2019

SELL
$2.19 - $2.7 $3,107 - $3,831
-1,419 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$1.92 - $2.85 $2,724 - $4,044
1,419 New
1,419 $4,000
Q4 2018

Feb 14, 2019

SELL
$1.7 - $3.58 $3,903 - $8,219
-2,296 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$3.35 - $4.14 $2,948 - $3,643
-880 Reduced 27.71%
2,296 $8,000
Q2 2018

Aug 14, 2018

BUY
$3.41 - $4.21 $4,876 - $6,020
1,430 Added 81.9%
3,176 $12,000
Q1 2018

May 15, 2018

BUY
$3.81 - $5.3 $6,652 - $9,253
1,746 New
1,746 $7,000
Q4 2017

Feb 14, 2018

SELL
$2.72 - $4.43 $587 - $956
-216 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$2.6 - $2.9 $561 - $626
216 New
216 $1,000
Q2 2017

Aug 14, 2017

SELL
N/A
-305 Closed
0 $0
Q1 2017

Nov 14, 2017

BUY
N/A
305
305 $1,000

Others Institutions Holding BMRA

About BIOMERICA INC


  • Ticker BMRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 13,427,700
  • Market Cap $4.03M
  • Description
  • Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...
More about BMRA
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.